A study yesterday in BMC Infectious Diseases by Pakistani researchers describes the wide range of invasive infections and high mortality rate associated with the multidrug-resistant fungus Candida auris.
Implementation of an antimicrobial stewardship program intervention at 27 nursing homes in North Carolina was associated with reductions in urine culture and culture-positive rates, according to a study today in Infection Control and Hospital Epidemiology. But high proportions of antimicrobial resistance were still observed among common urinary pathogens.
Confirmed and probable Candida auris cases in the United States through Mar 31 rose to 643, an increase of 56 from the end of February, the Centers for Disease Control and Prevention (CDC) said in an update yesterday.
Fluconazole during early pregnancy was linked to a more than double risk of miscarriage.
In a paper published yesterday in Emerging Infectious Diseases, a team of clinicians, infection control specialists, and pharmacists at a community hospital in Brooklyn described the management of patients with Candida auris bloodstream infections (fungemia).
The UK government today published a One Health report on antibiotic use and antibiotic resistance in animals and humans from 2013 through 2017, noting a 40% reduction of antibiotics in food-producing animals and a 9% decline in people.
Experts from the US Centers for Disease Control and Prevention (CDC) estimated yesterday in Antimicrobial Resistance & Infection Control that establishing nationwide antibiotic stewardship programs to prevent Clostridioides difficile infections in hospitals would result in an annual net benefit of $25.5 billion.
Staphylococcus aureus hospitalizations at US pediatric hospitals fell by 36% from 2009 to 2016, with methicillin-resistant S aureus (MRSA) declining by 52%, with a corresponding drop in antibiotic use, according to a study today in Infection Control and Hospital Epidemiology.
Temperature probes increased the risk of infection nearly 7 times.
A case report today from the Centers for Disease Control and Prevention (CDC) details the detection of a multidrug-resistant fungus in patients from three states.